ARGENX SE (ARGX) Executive Compensation
ARGENX SE (ARGX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ARGX
CIK: 1697862
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: P7
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EY Accountants B.V.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJohannes Lemmens
Audit LocationEindhoven, Netherlands
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-08 | 2026-10-08 | FORM 6-K | 0001104659-26-114491 | View SEC Doc Filr Page |
| 6-K | 2026-09-29 | 2026-09-29 | FORM 6-K | 0001104659-26-111631 | View SEC Doc Filr Page |
| 6-K | 2026-08-27 | 2026-08-27 | 6-K | 0001140361-26-034700 | View SEC Doc Filr Page |
| SC TO-T/A | 2026-08-27 | — | SC TO-T/A | 0001140361-26-034554 | View SEC Doc Filr Page |
| SC TO-T/A | 2026-08-19 | — | SC TO-T/A | 0001140361-26-033676 | View SEC Doc Filr Page |
| 6-K | 2026-08-17 | 2026-08-17 | FORM 6-K | 0001104659-26-097589 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000080255-26-000563 | View SEC Doc Filr Page |
| SC TO-T/A | 2026-08-06 | — | SC TO-T/A | 0001140361-26-031541 | View SEC Doc Filr Page |
| SC TO-T | 2026-08-06 | — | SC TO-T | 0001140361-26-031504 | View SEC Doc Filr Page |
| 6-K | 2026-08-03 | 2026-08-03 | FORM 6-K | 0001104659-26-089796 | View SEC Doc Filr Page |
| SC TO-C | 2026-07-28 | — | SC TO-C | 0001104659-26-087593 | View SEC Doc Filr Page |
| SC TO-C | 2026-07-27 | — | SC TO-C | 0001104659-26-087141 | View SEC Doc Filr Page |
| 6-K | 2026-07-27 | 2026-07-27 | FORM 6-K | 0001104659-26-086760 | View SEC Doc Filr Page |
| 6-K | 2026-07-23 | 2026-06-30 | 6-K | 0001697862-26-000033 | View SEC Doc Filr Page |
| 6-K | 2026-06-23 | 2026-06-23 | FORM 6-K | 0001104659-26-076606 | View SEC Doc Filr Page |
| 6-K | 2026-06-03 | 2026-06-03 | FORM 6-K | 0001104659-26-069786 | View SEC Doc Filr Page |
| 6-K | 2026-05-11 | 2026-05-08 | FORM 6-K | 0001104659-26-058143 | View SEC Doc Filr Page |
| 6-K | 2026-05-07 | 2026-03-31 | 6-K | 0001628280-26-031739 | View SEC Doc Filr Page |
| 6-K | 2026-05-06 | 2026-05-06 | FORM 6-K | 0001104659-26-056296 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-001108 | View SEC Doc Filr Page |
| 6-K | 2026-04-20 | 2026-04-20 | FORM 6-K | 0001104659-26-045083 | View SEC Doc Filr Page |
| 6-K | 2026-03-20 | 2026-03-20 | FORM 6-K | 0001104659-26-032739 | View SEC Doc Filr Page |
| 20-F | 2026-03-19 | 2025-12-31 | 20-F | 0001697862-26-000032 | View SEC Doc Filr Page |
| 6-K | 2026-03-19 | 2025-12-31 | 6-K | 0001697862-26-000030 | View SEC Doc Filr Page |
| 6-K | 2026-03-06 | 2026-03-06 | FORM 6-K | 0001104659-26-024353 | View SEC Doc Filr Page |